Parkinson’s disease: a patient-centric approach
Posted by
18-Jul-2012
At UCB, we try to look at healthcare from the perspective of people
living with chronic conditions. The driving question behind our work is,
“How will this make a difference to the lives of people living with
severe diseases?”
That is why we work with patient organisations to get a deeper understanding of how their condition affects their daily lives.
When it comes to Parkinson’s disease, for example, we know that relieving motor and underlying symptoms is important to people living with this condition, but also that being understood and supported is important, too.
Initiatives like More Than Motion, Parkinson’s Voices and the Parkinson’s Well-Being Map are our ways of supporting the community of people living with Parkinson’s disease.
In the end, of course, our primary goal is to bring medicines to people who need them. This week, we are pleased to report that people in the US living with Parkinson’s disease and Restless Leg Syndrome (RLS) will have access to another treatment option - one of our CNS treatments.
It takes an enormous research effort to develop a medicine, and a lot of work to bring it to the market.
We will continue to give back to the communities of patients we work with but, above all, we will keep striving to bring innovative medicines to people who need them.
That is why we work with patient organisations to get a deeper understanding of how their condition affects their daily lives.
When it comes to Parkinson’s disease, for example, we know that relieving motor and underlying symptoms is important to people living with this condition, but also that being understood and supported is important, too.
Initiatives like More Than Motion, Parkinson’s Voices and the Parkinson’s Well-Being Map are our ways of supporting the community of people living with Parkinson’s disease.
In the end, of course, our primary goal is to bring medicines to people who need them. This week, we are pleased to report that people in the US living with Parkinson’s disease and Restless Leg Syndrome (RLS) will have access to another treatment option - one of our CNS treatments.
It takes an enormous research effort to develop a medicine, and a lot of work to bring it to the market.
We will continue to give back to the communities of patients we work with but, above all, we will keep striving to bring innovative medicines to people who need them.
Leave a Comment